Erlotinib vs Nitroglycerin
Erlotinib vs Nitroglycerin: Overview
This comparison examines the pharmacological differences between Erlotinib and Nitroglycerin.
Mechanism of Action
Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.
Nitroglycerin: Nitric oxide donor causing venous and arterial vasodilation.
Pharmacokinetics
Half-life: Erlotinib β 36 hours; Nitroglycerin β 1-4 minutes.
Chemical Properties
Molecular Formula: Erlotinib β C22H23N3O4; Nitroglycerin β C3H5N3O9.
Molecular Weight: Erlotinib β 393.4380 g/mol; Nitroglycerin β 227.0870 g/mol.
Type: Erlotinib β Small molecule; Nitroglycerin β Small molecule.